Financial Ratios | Aspira Pathlab & Diagnostics Ltd. | R Wadiwala Securities Pvt Ltd

ASPIRA PATHLAB & DIAGNOSTICS LTD.

NSE : NABSE : 540788ISIN CODE : INE500C01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE59.801.6 (+2.75 %)
PREV CLOSE (Rs.) 58.20
OPEN PRICE (Rs.) 59.90
BID PRICE (QTY) 55.70 (20)
OFFER PRICE (QTY) 59.80 (35)
VOLUME 101
TODAY'S LOW / HIGH (Rs.)59.80 59.90
52 WK LOW / HIGH (Rs.) 4981
NSE
This Company is not listed in NSE

Financial Ratios

Select year
ParticularsMar2025Mar2024
Operational & Financial Ratios
   Earnings Per Share (Rs)1.97-2.60
   CEPS(Rs)3.42-1.10
   DPS(Rs)0.000.00
   Book NAV/Share(Rs)11.829.85
   Tax Rate(%)0.000.00
Margin Ratios
   Core EBITDA Margin(%)16.02-8.99
   EBIT Margin(%)10.77-17.45
   Pre Tax Margin(%)9.19-20.24
   PAT Margin (%)9.19-20.24
   Cash Profit Margin (%)15.98-8.58
Performance Ratios
   ROA(%)12.57-18.17
   ROE(%)18.13-26.34
   ROCE(%)19.27-20.54
   Asset Turnover(x)1.370.90
   Sales/Fixed Asset(x)1.240.77
   Working Capital/Sales(x)7.355.78
Efficiency Ratios
   Fixed Capital/Sales(x)0.811.30
   Receivable days38.1161.98
   Inventory Days7.9512.36
   Payable days72.32101.10
Valuation Parameters
   PER(x)43.370.00
   PCE(x)24.95-28.15
   Price/Book(x)7.213.15
   Yield(%)0.000.00
   EV/Net Sales(x)3.952.39
   EV/Core EBITDA(x)22.18-41.27
   EV/EBIT(x)36.62-13.71
   EV/CE(x)6.492.82
   M Cap / Sales3.992.42
Growth Ratio
   Net Sales Growth(%)66.600.00
   Core EBITDA Growth(%)611.070.00
   EBIT Growth(%)202.840.00
   PAT Growth(%)175.690.00
   EPS Growth(%)175.690.00
Financial Stability Ratios
   Total Debt/Equity(x)0.100.11
   Current Ratio(x)2.262.10
   Quick Ratio(x)2.051.89
   Interest Cover(x)6.82-6.27
   Total Debt/Mcap(x)0.010.03